The root of atractylodes macrocephala koidzumi prevents obesity and glucose intolerance and increases energy metabolism in mice

International Journal of Molecular Sciences

Volumn 19, Issue 1, 2018, Pages

  Song, Mi Young ^a   Lim, Soo Kyoung ^b   Wang, Jing Hua ^b   Kim, Hojun ^b  

^a Dongguk University   (South Korea)

^b Dongguk University   (South Korea)

Author keywords

Atractylodis Rhizoma Alba; Brown fat; Energy metabolism; Glucose intolerance; Obesity; Skeletal muscle

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; ATRACTYLODES MACROCEPHALA EXTRACT; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; NUCLEAR RESPIRATORY FACTOR 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; TRIACYLGLYCEROL; UNCOUPLING PROTEIN 1; BIOLOGICAL MARKER; PLANT EXTRACT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BODY WEIGHT GAIN; BROWN ADIPOSE TISSUE; CONTROLLED STUDY; ENERGY METABOLISM; GLUCOSE INTOLERANCE; HISTOLOGY; INSULIN RESISTANCE; INSULIN TOLERANCE TEST; LIPID LIVER LEVEL; LIPID STORAGE; MOUSE; MUSCLE ATROPHY; NONHUMAN; OBESITY; PLANT ROOT; PROTEIN EXPRESSION; THERMOGENESIS; WESTERN BLOTTING; ANIMAL; ATRACTYLODES; BLOOD; BODY WEIGHT; CHEMISTRY; DISEASE MODEL; DRUG EFFECT; GLUCOSE BLOOD LEVEL; LIPID DIET; LIPID METABOLISM; METABOLISM; SKELETAL MUSCLE;

ADIPOSE TISSUE, BROWN; ANIMALS; ATRACTYLODES; BIOMARKERS; BLOOD GLUCOSE; BODY WEIGHT; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; ENERGY METABOLISM; GLUCOSE INTOLERANCE; LIPID METABOLISM; MICE; MUSCLE, SKELETAL; OBESITY; PLANT EXTRACTS; PLANT ROOTS;

EID: 85040950205     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms19010278     Document Type: Article

References (36)

1. Moller, D.E. New drug targets for type 2 diabetes and the metabolic syndrome. Nature 2001, 414, 821-827. [CrossRef] [PubMed]
2. Tseng, Y.-H.; Cypess, A.M.; Kahn, C.R. Cellular bioenergetics as a target for obesity therapy. Nat. Rev. Drug Discov. 2010, 9, 465-482. [CrossRef] [PubMed]
3. Duchamp, C.; Barre, H. Skeletal muscle as the major site of nonshivering thermogenesis in cold-acclimated ducklings. Am. J. Physiol. 1993, 265, R1076-R1083. [CrossRef] [PubMed]
4. Cypess, A.M.; Kahn, C.R. Brown fat as a therapy for obesity and diabetes. Curr. Opin. Endocrinol. Diabetes Obes. 2010, 17, 143-149. [CrossRef] [PubMed]
5. Krssak, M.; Petersen, K.F.; Dresner, A.; DiPietro, L.; Vogel, S.; Rothman, D.; Shulman, G.; Roden, M. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: A 1H NMR spectroscopy study. Diabetologia 1999, 42, 113-116. [CrossRef] [PubMed]
6. Li, X.-T.; Kuang, H.-X.; Zhao, J. Why Is Qi-Invigorating Therapy in Chinese Medicine Suitable for Mitochondrial Diseases? A Bioenergetic Perspective; InTech: Rijeka, Croatia, 2015.
7. Wallace, D.C. Mitochondria as chi. Genetics 2008, 179, 727-735. [CrossRef] [PubMed]
8. Kim, S.J.; Shin, S.W.; Kim, H.J. Obesity from the viewpoint of metabolic rate. J. Korean Med. Obes. Res. 2003, 3, 95-105.
9. Li, X.-T. Investigation on the Mechanism of Qi-Invigoration from a Perspective of Effects of Sijunzi Decoction on Mitochondrial Energy Metabolism; InTech: Rijeka, Croatia, 2012.
10. Lee, S.H.; Lee, H.J.; Lee, Y.H.; Lee, B.W.; Cha, B.S.; Kang, E.S.; Ahn, C.W.; Park, J.S.; Kim, H.J.; Lee, E.Y. Korean red ginseng (Panax ginseng) improves insulin sensitivity in high fat fed Sprague-Dawley rats. Phytother. Res. 2012, 26, 142-147. [CrossRef] [PubMed]
11. The Korea Association of Herbology. Herbology; Younglimsa: Seoul, Korea, 1991; p. 536.
12. Huang, Y.; Wang, L.; Wang, S.; Cai, F.; Zheng, G.; Lu, A.; Yu, X.; Jiang, M. Treatment principles of obesity with chinese herbal medicine: Literature analysis by text mining. Engineering 2013, 5, 7-11. [CrossRef]
13. Wang, J.-H.; Bose, S.; Kim, H.-G.; Han, K.-S.; Kim, H. Fermented rhizoma Atractylodis macrocephalae alleviates high fat diet-induced obesity in association with regulation of intestinal permeability and microbiota in rats. Sci. Rep. 2015, 5, 8391. [CrossRef] [PubMed]
14. Kim, C.K.; Kim, M.; Oh, S.D.; Lee, S.-M.; Sun, B.; Choi, G.S.; Kim, S.-K.; Bae, H.; Kang, C.; Min, B.-I. Effects of Atractylodes macrocephala Koidzumi rhizome on 3T3-L1 adipogenesis and an animal model of obesity. J. Ethnopharmacol. 2011, 137, 396-402. [CrossRef] [PubMed]
15. Song, M.Y.; Kang, S.Y.; Oh, T.W.; Kumar, R.V.; Jung, H.W.; Park, Y.-K. The roots of Atractylodes macrocephala Koidzumi enhanced glucose and lipid metabolism in C2C12 myotubes via mitochondrial regulation. Evid. Based Complement Alternat. Med. 2015, 2015. [CrossRef] [PubMed]
16. Song, M.Y.; Jung, H.W.; Kang, S.Y.; Park, Y.-K. Atractylenolide III enhances energy metabolism by increasing the SIRT-1 and PGC1α expression with AMPK phosphorylation in C2C12 mouse skeletal muscle cells. Biol. Pharm. Bull. 2017, 40, 339-344. [CrossRef] [PubMed]
17. Kalyani, R.R.; Corriere, M.; Ferrucci, L. Age-related and disease-related muscle loss: The effect of diabetes, obesity, and other diseases. Lancet Diabetes Endocrinol. 2014, 2, 819-829. [CrossRef]
18. Jornayvaz, F.R.; Shulman, G.I. Regulation of mitochondrial biogenesis. Essays Biochem. 2010, 47, 69-84. [CrossRef] [PubMed]
19. Kang, C.; Li Ji, L. Role of PGC-1α signaling in skeletal muscle health and disease. Ann. N. Y. Acad. Sci. 2012, 1271, 110-117. [CrossRef] [PubMed]
20. Kim, S.H.; Plutzky, J. Brown fat and browning for the treatment of obesity and related metabolic disorders. Diabetes Metab. J. 2016, 40, 12-21. [CrossRef] [PubMed]
21. Caballero, B. The global epidemic of obesity: An overview. Epidemiol. Rev. 2007, 29, 1-5. [CrossRef] [PubMed]
22. Onakpoya, I.J.; Heneghan, C.J.; Aronson, J.K. Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: A systematic review. BMC Med. 2016, 14, 191. [CrossRef] [PubMed]
23. Daneschvar, H.L.; Aronson, M.D.; Smetana, G.W. FDA-approved anti-obesity drugs in the United States. Am. J. Med. 2016, 129, 879.e1-879.e6. [CrossRef] [PubMed]
24. Wang, C.-Y.; Liao, J.K. A mouse model of diet-induced obesity and insulin resistance. Methods Mol. Biol. 2012, 421-433. [CrossRef]
25. Jung, H.W.; Kang, A.N.; Kang, S.Y.; Park, Y.-K.; Song, M.Y. The root extract of Pueraria lobata and its main compound, puerarin, prevent obesity by increasing the energy metabolism in skeletal muscle. Nutrients 2017, 9, 33. [CrossRef] [PubMed]
26. Rouru, J.; Huupponen, R.; Pesonen, U.; Koulu, M. Subchronic treatment with metformin produces anorectic effect and reduces hyperinsulinemia in genetically obese Zucker rats. Life Sci. 1992, 50, 1813-1820. [CrossRef]
27. Rouru, J.; Pesonen, U.; Koulu, M.; Huupponen, R.; Santti, E.; Virtanen, K.; Rouvari, T.; Jhanwar-Uniyal, M. Anorectic effect of metformin in obese Zucker rats: Lack of evidence for the involvement of neuropeptide Y. Eur. J. Pharmacol. 1995, 273, 99-106. [CrossRef]
28. Lv, W.-S.; Wen, J.-P.; Li, L.; Sun, R.-X.; Wang, J.; Xian, Y.-X.; Cao, C.-X.; Wang, Y.-L.; Gao, Y.-Y. The effect of metformin on food intake and its potential role in hypothalamic regulation in obese diabetic rats. Brain Res. 2012, 1444, 11-19. [CrossRef] [PubMed]
29. Xu, J.; Lloyd, D.J.; Hale, C.; Stanislaus, S.; Chen, M.; Sivits, G.; Vonderfecht, S.; Hecht, R.; Li, Y.-S.; Lindberg, R.A. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice. Diabetes 2009, 58, 250-259. [CrossRef] [PubMed]
30. Liang, H.; Ward, W.F. PGC-1α: A key regulator of energy metabolism. Adv. Physiol. Educ. 2006, 30, 145-151. [CrossRef] [PubMed]
31. Liu, C.; Lin, J.D. PGC-1 coactivators in the control of energy metabolism. Acta Biochim. Biophys. Sin. 2011, 43, 248-257. [CrossRef] [PubMed]
32. O’Neill, H.M.; Holloway, G.P.; Steinberg, G.R. AMPK regulation of fatty acid metabolism and mitochondrial biogenesis: Implications for obesity. Mol. Cell. Endocrinol. 2013, 366, 135-151. [CrossRef] [PubMed]
33. Jäger, S.; Handschin, C.; St-Pierre, J.; Spiegelman, B.M. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of Pgc-1α. Proc. Natl. Acad. Sci. USA 2007, 104, 12017-12022. [CrossRef] [PubMed]
34. Zurlo, F.; Larson, K.; Bogardus, C.; Ravussin, E. Skeletal muscle metabolism is a major determinant of resting energy expenditure. J. Clin. Investig. 1990, 86, 1423-1427. [CrossRef] [PubMed]
35. Sandri, M.; Lin, J.; Handschin, C.; Yang, W.; Arany, Z.P.; Lecker, S.H.; Goldberg, A.L.; Spiegelman, B.M. Pgc-1α protects skeletal muscle from atrophy by suppressing foxo3 action and atrophy-specific gene transcription. Proc. Natl. Acad. Sci. USA 2006, 103, 16260-16265. [CrossRef] [PubMed]
36. Parlee, S.D.; Lentz, S.I.; Mori, H.; MacDougald, O.A. Quantifying size and number of adipocytes in adipose tissue. Methods Enzymol. 2014, 537, 93-122. [CrossRef] [PubMed]